Chris W Bodine

CIK 1194405 · Executive Vice President · last filed 2025-10-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$28.02M

Companies

Total Filings

Lifetime Open-Market Net

-$18.85M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

CVS price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest

OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address

ONE CVS DR
WOONSOCKET, RI 02895

Related Filers

Actavis plc — 17 joint filings, latest 2020-05-11

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
ONEW	Director	33,928	$9.49	$322.0K	$0	9	2025-10-06
Allergan plc (AGN) Delisted	Director	0	—	—	$499.3K	11	2020-05-11
ACT	Director	12,222	$48.29	$590.2K	$0	2	2015-06-08
Actavis, Inc. (WPI) Delisted	Director	15,352	—	—	$0	4	2012-05-14
CVS	Executive Vice President	293,003	$92.53	$27.11M	-$19.34M	9	2009-02-20

Recent Filings · Page 2 of 5

43 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2020-05-04	Allergan plc (AGN) Delisted	Tax (F)	−991	-$188.0K	EDGAR
2020-03-04	ONEW	Grant (A)	+6,250	$0	EDGAR
2019-05-02	Allergan plc (AGN) Delisted	Mixed	+1,111	$159.9K	EDGAR
2018-05-04	Allergan plc (AGN) Delisted	Grant (A)	+1,985	$299.9K	EDGAR
2018-05-03	Allergan plc (AGN) Delisted	Tax (F)	−588	-$89.9K	EDGAR
2017-12-07	Allergan plc (AGN) Delisted	Buy (P)	+3,030	$499.3K	EDGAR
2017-05-05	Allergan plc (AGN) Delisted	Mixed	+555	$137.1K	EDGAR
2016-08-09	Allergan plc (AGN) Delisted	Grant (A)	+201	$49.9K	EDGAR
2016-05-09	Allergan plc (AGN) Delisted	Grant (A)	+1,188	$249.9K	EDGAR
2015-08-25	Allergan plc (AGN) Delisted	Gift (G)	−158	$0	EDGAR

Showing 11–20 of 43

Prev Page 2 of 5 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.